186 related articles for article (PubMed ID: 20632394)
21. [Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].
Yerebakan C; Uğurlucan M; Kaminski A; Westphal B; Liebold A; Steinhoff G
Anadolu Kardiyol Derg; 2009 Dec; 9(6):457-64. PubMed ID: 19965315
[TBL] [Abstract][Full Text] [Related]
22. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.
Ahmadi H; Baharvand H; Ashtiani SK; Soleimani M; Sadeghian H; Ardekani JM; Mehrjerdi NZ; Kouhkan A; Namiri M; Madani-Civi M; Fattahi F; Shahverdi A; Dizaji AV
Curr Neurovasc Res; 2007 Aug; 4(3):153-60. PubMed ID: 17691968
[TBL] [Abstract][Full Text] [Related]
23. [Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function].
Suárez de Lezo J; Herrera C; Pan M; Romero M; Pavlovic D; Segura J; Sánchez J; Ojeda S; Torres A
Rev Esp Cardiol; 2007 Apr; 60(4):357-65. PubMed ID: 17521544
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
[TBL] [Abstract][Full Text] [Related]
25. The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial.
Leone AM; D'Amario D; Teofili L; Basile E; Cannata F; Graziani F; Marzilli M; Russo AM; Tarantini G; Ceconi C; Leone G; Trani C; Rebuzzi AG; Crea F
Trials; 2016 Feb; 17():97. PubMed ID: 26891753
[TBL] [Abstract][Full Text] [Related]
26. Intracoronary infusion of selected autologous bone marrow stem cells improves longitudinal myocardial strain and strain rate in patients with old anterior myocardial infarction without recent revascularization.
Karatasakis G; Leontiadis E; Peristeri I; Manginas A; Goussetis E; Graphakos S; Papadakis E; Cokkinos DV
Eur J Echocardiogr; 2010 Jun; 11(5):440-5. PubMed ID: 20308191
[TBL] [Abstract][Full Text] [Related]
27. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
[TBL] [Abstract][Full Text] [Related]
28. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial.
Tarui S; Ishigami S; Ousaka D; Kasahara S; Ohtsuki S; Sano S; Oh H
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1198-1207, 1208.e1-2. PubMed ID: 26232942
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction.
Obradović S; Rusović S; Balint B; Ristić-Andelkov A; Romanović R; Baskot B; Vojvodić D; Gligić B
Vojnosanit Pregl; 2004; 61(5):519-29. PubMed ID: 15551805
[TBL] [Abstract][Full Text] [Related]
30. A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy.
Pincott ES; Ridout D; Brocklesby M; McEwan A; Muthurangu V; Burch M
J Heart Lung Transplant; 2017 Aug; 36(8):837-844. PubMed ID: 28162930
[TBL] [Abstract][Full Text] [Related]
31. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
[TBL] [Abstract][Full Text] [Related]
32. The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.
Raval AN; Cook TD; Duckers HJ; Johnston PV; Traverse JH; Abraham WT; Altman PA; Pepine CJ
Am Heart J; 2018 Jul; 201():141-148. PubMed ID: 29803986
[TBL] [Abstract][Full Text] [Related]
33. [Mobilization effects of SCF along with G-CSF on bone marrow stem cells and endothelial progenitor cells in rats with unilateral ureteral obstruction].
Zhang JJ; Yi ZW; Dang XQ; He XJ; Wu XC
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):144-8. PubMed ID: 17448311
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
[TBL] [Abstract][Full Text] [Related]
35. Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.
Musialek P; Tekieli L; Kostkiewicz M; Miszalski-Jamka T; Klimeczek P; Mazur W; Szot W; Majka M; Banys RP; Jarocha D; Walter Z; Krupinski M; Pieniazek P; Olszowska M; Zmudka K; Pasowicz M; Kereiakes DJ; Tracz W; Podolec P; Wojakowski W
Circ Cardiovasc Imaging; 2013 Mar; 6(2):320-8. PubMed ID: 23271789
[TBL] [Abstract][Full Text] [Related]
36. [Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction].
Balogh L; Czuriga I; Hunyadi J; Galuska L; Kristóf E; Edes I
Orv Hetil; 2007 Feb; 148(6):243-9. PubMed ID: 17344174
[TBL] [Abstract][Full Text] [Related]
37. Transcoronary infusion of bone marrow derived multipotent stem cells to preserve left ventricular geometry and function after myocardial infarction.
Boonbaichaiyapruck S; Pienvichit P; Limpijarnkij T; Rerkpattanapipat P; Pongpatananurak A; Saelee R; Ungkanont A; Hongeng S
Clin Cardiol; 2010 Jul; 33(7):E10-5. PubMed ID: 20552656
[TBL] [Abstract][Full Text] [Related]
38. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
[TBL] [Abstract][Full Text] [Related]
39. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
Assmus B; Schächinger V; Teupe C; Britten M; Lehmann R; Döbert N; Grünwald F; Aicher A; Urbich C; Martin H; Hoelzer D; Dimmeler S; Zeiher AM
Circulation; 2002 Dec; 106(24):3009-17. PubMed ID: 12473544
[TBL] [Abstract][Full Text] [Related]
40. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
Pasquet S; Sovalat H; Hénon P; Bischoff N; Arkam Y; Ojeda-Uribe M; Bouar Rl; Rimelen V; Brink I; Dallemand R; Monassier JP
Cytotherapy; 2009; 11(8):1002-15. PubMed ID: 19929464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
